Grantham, Mayo, Van Otterloo & Co (GMO)’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-50,300
| Closed | -$2.3M | – | 823 |
|
|
2020
Q3 | $2.3M | Sell |
50,300
-36,800
| -42% | -$1.68M | 0.02% | 382 |
|
|
2020
Q2 | $4.37M | Buy |
87,100
+5,800
| +7% | +$291K | 0.03% | 263 |
|
|
2020
Q1 | $4.18M | Buy |
+81,300
| New | +$4.18M | 0.03% | 265 |
|
|
2018
Q2 | – | Sell |
-6,700
| Closed | -$542K | – | 557 |
|
|
2018
Q1 | $542K | Sell |
6,700
-5,600
| -46% | -$453K | ﹤0.01% | 461 |
|
|
2017
Q4 | $722K | Buy |
+12,300
| New | +$722K | ﹤0.01% | 376 |
|